Mark Brittan

Parkinson disease

Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats

l-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain

The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease

Therapeutic potential of β-arrestin- and G protein-biased agonists

The Physiology, Signaling, and Pharmacology of Dopamine Receptors

The Acute and Chronic Effects of MDMA (“Ecstasy”) on Cortical 5-HT2A Receptors in Rat and Human Brain

Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient

Upregulation of striatal D2 receptors in the MPTP-treated vervet monkey is reversed by grafts of fetal ventral mesencephalon: an autoradiographic study